These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 27853889

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Choroidal thickness in Behcet's uveitis: an enhanced depth imaging-optical coherence tomography and its association with angiographic changes.
    Kim M, Kim H, Kwon HJ, Kim SS, Koh HJ, Lee SC.
    Invest Ophthalmol Vis Sci; 2013 Sep 05; 54(9):6033-9. PubMed ID: 23900605
    [Abstract] [Full Text] [Related]

  • 27. Efficacy, retention rate and safety of adalimumab treatment in patients with non-infectious uveitis and scleritis: a real-world, retrospective, single-centre study.
    Çam F, Celiker H.
    Eye (Lond); 2024 Apr 05; 38(5):893-901. PubMed ID: 37884704
    [Abstract] [Full Text] [Related]

  • 28. Intravitreal adalimumab for refractory uveitis-related macular edema.
    Androudi S, Tsironi E, Kalogeropoulos C, Theodoridou A, Brazitikos P.
    Ophthalmology; 2010 Aug 05; 117(8):1612-6. PubMed ID: 20378179
    [Abstract] [Full Text] [Related]

  • 29. The Efficacy of Adalimumab as an Initial Treatment in Patients with Behçet's Retinal Vasculitis.
    Yang S, Huang Z, Hu Y, Zhang J, Liu X, Li H, Xie L, Wen F, Liang D, Su W.
    Front Pharmacol; 2021 Aug 05; 12():609148. PubMed ID: 34239438
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Ultra-Widefield Fluorescein Angiography to Monitor Therapeutic Response to Adalimumab in Behcet's Uveitis.
    Kim BH, Park UC, Park SW, Yu HG.
    Ocul Immunol Inflamm; 2022 Aug 05; 30(6):1347-1353. PubMed ID: 33793368
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Comparison of conventional immunosuppressive drugs versus anti-TNF-α agents in non-infectious non-anterior uveitis.
    Leclercq M, Langlois V, Girszyn N, Le Besnerais M, Benhamou Y, Levesque H, Muraine M, Gueudry J.
    J Autoimmun; 2020 Sep 05; 113():102481. PubMed ID: 32586650
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Efficacy and Safety of Adalimumab in Patients with Behçet Uveitis: A Systematic Review and Meta-Analysis.
    Sener H, Evereklioglu C, Horozoglu F, Gunay Sener AB.
    Ocul Immunol Inflamm; 2024 Jan 05; 32(1):89-97. PubMed ID: 36625549
    [Abstract] [Full Text] [Related]

  • 38. Long-term data on efficacy and safety of adalimumab in Behçet's disease.
    van der Houwen TB, Humer B, Missotten TO, Thiadens AAHJ, van Hagen PM, van Laar JAM.
    Clin Immunol; 2023 Feb 05; 247():109242. PubMed ID: 36717068
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.